Apollo Hospitals Enterprise Limited (BOM:508869)
India · Delayed Price · Currency is INR 8,955.00
-31.40 (-0.35%)
At close: Jul 31, 2026
BOM:508869 Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Revenue | 252,285 | 217,940 | 190,592 | 166,125 | 146,626 |
| 252,285 | 217,940 | 190,592 | 166,125 | 146,626 | |
Revenue Growth | 15.76% | 14.35% | 14.73% | 13.30% | 38.85% |
Cost of Revenue | 160,759 | 144,440 | 126,608 | 109,446 | 95,317 |
Gross Profit | 91,526 | 73,500 | 63,984 | 56,679 | 51,309 |
Selling, General & Admin | - | 7,185 | 8,104 | 7,829 | 4,669 |
Other Operating Expenses | 53,833 | 35,983 | 31,937 | 28,204 | 24,749 |
Operating Expenses | 62,594 | 50,743 | 46,911 | 42,187 | 35,425 |
Operating Income | 28,932 | 22,757 | 17,073 | 14,492 | 15,884 |
Interest Expense | -4,496 | -4,225 | -4,101 | -3,137 | -3,304 |
Interest & Investment Income | - | 930 | 429 | 445 | 351 |
Earnings From Equity Investments | 449 | 330 | 180 | -432 | 73 |
Currency Exchange Gain (Loss) | - | - | - | 3 | 6 |
Other Non Operating Income (Expenses) | 1,916 | -135 | -153 | -532 | -310 |
EBT Excluding Unusual Items | 26,801 | 19,657 | 13,428 | 10,839 | 12,700 |
Gain (Loss) on Sale of Investments | - | 774 | 374 | 285 | 253 |
Gain (Loss) on Sale of Assets | - | -63 | -36 | -150 | -40 |
Other Unusual Items | -192 | 23 | 39 | 31 | 2,941 |
Pretax Income | 26,609 | 20,391 | 13,805 | 11,005 | 15,854 |
Income Tax Expense | 6,582 | 5,340 | 4,455 | 2,562 | 4,770 |
Earnings From Continuing Operations | 20,027 | 15,051 | 9,350 | 8,443 | 11,084 |
Minority Interest in Earnings | -610 | -592 | -364 | -252 | -528 |
Net Income | 19,417 | 14,459 | 8,986 | 8,191 | 10,556 |
Net Income to Common | 19,417 | 14,459 | 8,986 | 8,191 | 10,556 |
Net Income Growth | 34.29% | 60.91% | 9.71% | -22.40% | 601.86% |
Shares Outstanding (Basic) | 144 | 144 | 144 | 144 | 144 |
Shares Outstanding (Diluted) | 144 | 144 | 144 | 144 | 144 |
Shares Change | 0.08% | - | - | - | 2.71% |
EPS (Basic) | 135.04 | 100.56 | 62.50 | 56.97 | 73.42 |
EPS (Diluted) | 134.94 | 100.56 | 62.50 | 56.97 | 73.42 |
EPS Growth | 34.19% | 60.91% | 9.71% | -22.40% | 583.57% |
Additional Metrics
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Free Cash Flow | 8,937 | 4,237 | 7,834 | 2,484 | 10,388 |
Free Cash Flow Per Share | 62.11 | 29.47 | 54.48 | 17.28 | 72.25 |
Dividend Per Share | 20.000 | 19.000 | 16.000 | 15.000 | 11.750 |
Dividend Growth | 5.26% | 18.75% | 6.67% | 27.66% | 291.67% |
Gross Margin | 36.28% | 33.73% | 33.57% | 34.12% | 34.99% |
Operating Margin | 11.47% | 10.44% | 8.96% | 8.72% | 10.83% |
Profit Margin | 7.70% | 6.63% | 4.71% | 4.93% | 7.20% |
Free Cash Flow Margin | 3.54% | 1.94% | 4.11% | 1.49% | 7.08% |
EBITDA | 37,693 | 27,982 | 22,115 | 19,106 | 20,455 |
EBITDA Margin | 14.94% | 12.84% | 11.60% | 11.50% | 13.95% |
D&A For EBITDA | 8,761 | 5,225 | 5,042 | 4,614 | 4,571 |
EBIT | 28,932 | 22,757 | 17,073 | 14,492 | 15,884 |
EBIT Margin | 11.47% | 10.44% | 8.96% | 8.72% | 10.83% |
Effective Tax Rate | 24.74% | 26.19% | 32.27% | 23.28% | 30.09% |
Revenue as Reported | 254,201 | 219,943 | 191,655 | 167,028 | 147,408 |